Sarepta Gene Therapy Report Is Chance at Redemption After $6 Billion Wipeout

(Bloomberg) -- Sarepta Therapeutics Inc. has a chance to shake off a summer slump -- which cut shares in half from a July peak and wiped out $6 billion in market value -- when the drugmaker present...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.